FR054
FR054 is an inhibitor of the HBP enzyme PGM3, with a remarkable anti-breast cancer effect[1].
Product Specifications
CAS Number
[35954-65-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fr054.html
Purity
99.46
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(O[C@@H]1[C@]2([H])[C@](OC(C)=N2)([H])O[C@@H]([C@H]1OC(C)=O)COC(C)=O)=O
Molecular Formula
C14H19NO8
Molecular Weight
329.30
Precautions
H302, H315, H319, H335
References & Citations
[1]Francesca Ricciardiello, et al. Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. Cell Death Dis. 2018 Mar 7;9 (3) :377.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
406744-01 50 µL
MSRB2 (Methionine-R-Sulfoxide Reductase B2, Mitochondrial, MsrB2, CBS-1, MSRB, CGI-131)
Ask
View Details 406744-02 100 µL
MSRB2 (Methionine-R-Sulfoxide Reductase B2, Mitochondrial, MsrB2, CBS-1, MSRB, CGI-131)
Ask
View Details GTR15333725 1 Vial
Lentiviral human TP53TG3D shRNA (UAS) - Lentiviral human TP53TG3D shRNA (UAS, iRFP) (25)
Ask
View Details 
